Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

Navigator models, particularly cross-specialty nurse navigation, reduce stress, expedite diagnosis-to-treatment transitions, ...

Clinical Skills Institute expands its $900 online medical assistant program, preparing students for the NHA CCMA exam ...

Non–muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) continue to pose significant clinical and health-economic challenges in ...

The initiative offers student loan repayment to nursing & therapy graduates and to current employees, including ...

Edward M.R. Macfarlane’s weServed™ platform creates a unified digital ecosystem to bridge gaps between the NHS, charities, ...

Understand the signs of premature ovarian failure and POI. Learn how to manage symptoms and protect your long-term health.

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

Enhanced Phase 2 dose-optimization study designed to accelerate development and support a streamlined Phase 3 programMELBOURNE, Australia and NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex ...

New molecular insights into the link between hepatocellular carcinoma and intratumoral fibrosis could lead to better ...

CanVeer Biopharma Inc. (the “Company” or “CanVeer”), a biopharma company advancing innovative therapeutics for severe ...